0001209191-14-020862.txt : 20140317
0001209191-14-020862.hdr.sgml : 20140317
20140317112054
ACCESSION NUMBER: 0001209191-14-020862
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140313
FILED AS OF DATE: 20140317
DATE AS OF CHANGE: 20140317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVY BRIAN
CENTRAL INDEX KEY: 0001277458
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 14696546
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-03-13
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001277458
LEVY BRIAN
C/O AERIE PHARMACEUTICALS, INC.
135 U.S. HIGHWAY 206, SUITE 15
BEDMINSTER
NJ
07921
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
20.70
2014-03-13
4
A
0
115000
0.00
A
2024-03-13
Common Stock
115000
115000
D
This option was granted on March 13, 2014 and is scheduled to vest with respect to 25% of the underlying shares on March 13, 2015, and thereafter in 36 equal installments on each monthly anniversary of the date of grant.
/s/ Richard J. Rubino, Attorney-in-Fact for Brian Levy
2014-03-17